Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions

COVID-19 is a novel infectious disease caused by the severe acute respiratory distress (SARS)-coronavirus-2 (SARS-CoV-2). Several therapeutic options are currently emerging but none with universal consensus or proven efficacy. Solid organ transplant recipients are perceived to be at increased risk o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Drug Monit
Main Authors: Elens, Laure, Langman, Loralie J., Hesselink, Dennis A., Bergan, Stein, Moes, Dirk Jan A.R., Molinaro, Mariadelfina, Venkataramanan, Raman, Lemaitre, Florian
Formato: Artigo
Idioma:Inglês
Publicado em: Therapeutic Drug Monitoring 2020
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7188032/
https://ncbi.nlm.nih.gov/pubmed/32304488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados